The SDC-1 protein coordinately regulates the sex determination and dosage compensation pathways in C. elegans . Genetic evidence indicates that SDC-1 works in concert with SDC-2 and SDC-3 to direct sexual fate and reduce X expression in hermaphrodites. SDC-1 is a 139 kD protein that contains seven putative zinc finger DNA binding domains. Mutations in
sdc-1 cause partial masculinization of most XX animals but have no effect on males (XO). This defect is caused by aberrant regulation of the male-specific
her-1 gene (Villeneuve and Meyer 1987, Cell , 48:25-37) and results in elevated
her-1 transcript levels in
sdc-1 mutant hermaphrodites (Trent et al. 1991, Mech. Dev. , 34:43-56). We asked if SDC-1 binds directly to the
her-1 promoter to repress its transcription. To do so, we created extrachromosomal arrays carrying multiple copies of (1) the
her-1 promoter region, (2) transgenes encoding a GFP-LacI fusion protein and (3) lacO , the binding site for the LacI repressor protein. Arrays were visualized by GFP fluorescence through confocal microscopy. Using anti-SDC-1 antibodies, we found that SDC-1 colocalizes to the
her-1 promoter. SDC-2 and SDC-3 also localize to the
her-1 promoter (see abstract by Dawes, H. et al.) indicating that SDC-1 works in combination with SDC-2 and SDC-3 to repress
her-1 transcription directly.
sdc-1 mutants also disrupt dosage compensation, causing elevated X-linked gene transcripts and dumpy and egg-laying defective phenotypes. Interestingly, though mutations in all other dosage compensation genes affect the abundance or localization of the dosage compensation complex,
sdc-1 mutations fail to perturb the complex. By immunostaining, we found that SDC-1 localizes to the X chromosome and colocalizes with other dosage compensation complex members such as SDC-3 and DPY-28. Therefore, SDC-1 may directly modulate the activity of the dosage compensation complex once assembled on X rather than contributing to its assembly or localization.